22 September 2015 - Deborah Wilkes
Archived
China's Biostime International Holdings is acquiring an 83% stake in the Australian vitamins, minerals and supplements (VMS) specialist Swisse Wellness for A$1.39 billion (US$0.98 billion).
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.